Dr. Andy Whittamore, a GP and clinical lead at Asthma and Lung UK, shed light on four chronic lung conditions that tend to ...
For individuals with chronic lung conditions, the winter season and the current cold snap poses significant challenges.
Ritu Baral, an analyst from TD Cowen, maintained the Buy rating on Insmed (INSM – Research Report). The associated price target remains the ...
The main treatment for this condition is antibiotics. “Bronchiectasis can only be diagnosed by lung scans, but GPs can suspect it if somebody’s getting lots of infections or lots of mucus or ...
In a report released today, Ritu Baral from TD Cowen maintained a Buy rating on Insmed (INSM – Research Report), with a price target of $98.00.
A former nurse with multiple health conditions says she "owes her life" to support groups she says helped her through the ...
Insmed Incorporated (Nasdaq: INSM), a people-first global biopharmaceutical company striving to deliver first- and ...